Quantcast
Last updated on April 24, 2014 at 10:01 EDT

Latest Gardasil Stories

2014-02-12 08:29:58

ST. PAUL, Minn., Feb. 12, 2014 /PRNewswire-USNewswire/ -- Four leading national medical associations -- the American Academy of Family Physicians (AAFP), the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and American College of Obstetricians and Gynecologists (ACOG) -- together with the Immunization Action Coalition and the Centers for Disease Control and Prevention, have issued a call urging physicians across the U.S. to educate their patients about...

2014-02-10 08:26:48

Report Outlines Recommendations to Overcome Barriers and Support Cancer Prevention Efforts WASHINGTON, Feb. 10, 2014 /PRNewswire-USNewswire/ -- Achieving widespread HPV (human papillomavirus) vaccination is one of the most profound opportunities for cancer prevention, according to a report released today by the President's Cancer Panel. The Panel's report, Accelerating HPV Vaccine Uptake: Urgency for Action to Prevent Cancer, issues an urgent call for energizing efforts to reach the HPV...

2014-01-22 10:33:54

The risk of developing cervical cancer can be significantly decreased through human papillomavirus (HPV) vaccination.  Despite calls from leading health and professional organizations for universal vaccination for girls ages 11 and 12, the most recently published national data indicate that only 14.5 percent of 11- and 12-year-old girls have received at least one dose of the HPV vaccine and 3 percent have completed the three-dose series. A new Moffitt Cancer Center study provides insight...

2014-01-08 12:29:02

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:MarketVIEW: HPV therapeutic vaccinesHuman papilloma viruses (HPV) members of the papillomaviridae family are extremely common with an estimated worldwide prevalence of ~11-12%. Although nearly all sexually-active men and women acquire the virus at some point in their lives, most infections are asymptomatic and self-limiting; with 90% clearing within 2 years. High risk forms of HPV (16/18)...

2013-12-11 08:30:47

BLUE BELL, Pa., Dec. 11, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that Dr. J. Joseph Kim, President and CEO, has been invited to participate on an expert panel titled, Ovarian & Cervical Cancer - Evaluating the Role of Immunotherapy Exploring Three Approaches - Dendritic Cells, DNA Plasmids & Liposomal Delivery. Dr. Kim will discuss Inovio's DNA immunotherapy VGX-3100, which was designed to treat cervical pre-cancers and cancers, head...

2013-12-06 23:24:00

An article published on November 19, 2013 on the Center for Advancing Health website, reported on a study that suggested a relationship between the Gardasil media coverage and the number of reported side effects (1). polyDNA reviews the article and recommends Gene-Eden-VIR to safely target the latent HPV. Rochester, NY (PRWEB) December 06, 2013 A study published in the Journal of Adolescent Health found a correlation between media coverage and the number of side effects reported on...

2013-11-26 13:40:27

Barriers to human papillomavirus (HPV) vaccination among adolescents in the U.S. range from financial concerns and parental attitudes to social influences and concerns about the vaccination's effect on sexual behavior, according to a review of the available medical literature published by JAMA Pediatrics, a JAMA Network publication. HPV vaccine coverage among teenagers has increased since the vaccine was licensed in 2006 but it still remains low compared with other recommended...

HPV vaccine effective in one dose
2013-11-04 11:44:37

Brett Smith for redOrbit.com - Your Universe Online An HPV vaccine that guards against cervical cancer was shown to be effective in just one dose, instead of the recommended three, according to a new study published by the journal Cancer Prevention Research. The study researchers found that one dose of the vaccine for human papillomavirus (HPV), the disease known to cause cervical cancer, established antibodies that remained stable in the blood for four years. The team said their study was...

2013-07-30 23:29:10

A new study, published in the Journal of Cancer Education on July 16, 2013, says that Latina women are “less likely to be aware of HPV and the HPV vaccine than non-Latina women, and fewer Latinas were vaccinated than non-Latina women. (1)” polyDNA recommends that Latina women familiarize themselves with Gene-Eden-VIR, the natural HPV remedy. Rochester, NY (PRWEB) July 30, 2013 Latina women have many misconceptions about the Human Papillomavirus (HPV) and the various remedies and...

2013-07-23 11:43:30

A look at factors associated with vaccine’s low rate of adoption Improving vaccination rates against the human papillomavirus (HPV) in boys aged 11 to 21 is key to protecting both men and women, says new research from University of Toronto Professor Peter A. Newman from the Factor-Inwentash Faculty of Social Work. HPV has been linked to anal, penile and certain types of throat cancers in men. Since the virus is also responsible for various cancers in women, vaccinating...